Zantac cancer court cases loom

Mass international litigation could cost pharma companies up to $66 billion, say analysts Pharmaceutical companies which have sold antacid drug Zantac (ranitidine) could face multi-billions of dollars in damages if thousands of court cases claiming it causes cancer are successful. Some 160,000 consumers have filed claims in a US federal registry and, according to Bloomberg